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Abstract 
Theoretical and experimental evidences support the hypothesis that extremely low-frequency 
electromagnetic fields can affect voltage-gated channels. Little is known, however, about their 
effect on potassium channels. Kv1.3, a member of the voltage-gated potassium channels family 
originally discovered in the brain, is a key player in important biological processes including 
antigen-dependent activation of T-cells during the immune response. We report that Kv1.3 
expressed in CHO-K1 cells can be modulated in cell subpopulations by extremely low frequency 
and relatively low intensity electromagnetic fields. In particular, we observed that field exposure 
can cause an enhancement of Kv1.3 potassium conductance and that the effect lasts for several 
minutes after field removal. The results contribute to put immune and nervous system responses to 
extremely low-frequency electromagnetic fields into a new perspective, with Kv1.3 playing a 
pivotal molecular role. 
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INTRODUCTION 
Electromagnetic fields in the 0.03 – 300 Hz frequency range are commonly known as extremely 
low-frequency electromagnetic fields (ELF-EMF) and are found in the public or domestic 
environment with intensities up to several hundreds of μT near appliances [World Health 
Organization (WHO), 2015]. Several studies provided evidence that exposure to ELF-EMF can 
cause biological effects, such as a modulation of cell proliferation and differentiation, but molecular 
actors behind such cellular responses remain to be identified [Funk et al., 2009]. In mammalian 
cells, voltage-gated ion channels (VGC) are among suitable candidates. In fact, theoretical models 
[Funk et al., 2009] and experimental studies on calcium [Pall, 2013] and sodium channels [He et al., 
2013] support this hypothesis, with fields that may act on the channel directly or by interposition of 
cellular signalling pathways [Gartzke and Lange, 2002; Funk et al., 2009; He et al., 2013; Pall, 
2013]. Yet, effects on VGC of the potassium family, Kv, are mostly unexplored, except for the 
recent work of [Gavoçi et al., 2013] reporting that an AC low-frequency (8 Hz) and low-intensity 
(100 µT) field was not altering Tetraethylammonium (TEA)-sensitive potassium currents in 
neuroblastoma cells. 
Kv channels are of paramount importance in cell physiology and represent one of the most diverse 
and ubiquitous families of membrane proteins. The Kv superfamily comprises 12 subfamilies (Kv1-
Kv12), all formed by tetrameric membrane-spanning protein complexes that create a selective pore 
for potassium ions. Each subunit is formed by six transmembrane segments (S1-S6), with S1-S4 
constituting a voltage sensor domain (VSD) and S5-S6 the pore-forming region [Coetzee et al., 
1999; Gutman et al., 2003]. Kv1.3  is a member of the Shaker (Kv1) delayed rectifier family and it 
was identified in the brain and in several regions throughout the body [Swanson et al., 1990; 
Bielanska et al., 2009; Bielanska et al., 2010]. In particular, although mainly expressed in the 
olfactory bulb and lymphocytes [Duque et al., 2013], Kv1.3 is found in the hippocampus [Veh et al., 
1995], epithelia [Grunnet et al., 2003], adipose tissue [Xu et al., 2004], and both skeletal and 
smooth muscle [Villalonga et al., 2008; Bielanska et al., 2012a; Bielanska et al., 2012b]. 
Intriguingly, in addition to the plasma membrane, the channel’s presence in mitochondria has been 
recently demonstrated [Szabo and Zoratti, 2014; Szabò et al., 2010]. 
Kv1.3 has attracted much attention for playing diverse biological functions relevant to clinics. 
Above all, it is involved in antigen-dependent T-cells activation during the immune response 
together with the Ca2+-activated IKCa1 K+ channel, and is therefore considered a potentially 
elective therapeutic target for immunomodulation [Beeton et al., 2001; George Chandy et al., 2004; 
Gocke et al., 2012; Hansen, 2014; Kahlfuß et al., 2014; Panyi, 2005; Wang and Xiang, 2013; Wulff 
et al., 2003]. Furthermore, it is assumed to contribute to class-switching of memory B cells [Wulff 
et al., 2004]. Along with such immune system-specific functions, Kv1.3 has been also proposed to 
contribute to modulation of sensitivity to insulin [Upadhyay et al., 2013] and to the regulation of 
crucial cellular processes such as apoptosis [Gulbins et al., 2010; Szabò et al., 2010] and 
proliferation [Bielanska et al., 2009]. 
 
In the present work, we investigated the effect of ELF-EMF on Kv1.3 expressed in CHO-K1 cells. 
We focused on whole-cell conductance, which was found to be enhanced in cell subpopulations by 
relatively low-intensity fields in the order of hundreds of µT. 
 
MATERIALS AND METHODS 
Cell culture and Kv1.3 channel transfection 
CHO-K1 cells (ATCC, USA) were cultured in 35 mm Petri dishes (density: 2 x 103 cells/cm2) and 
maintained in F-12 Nutrient Mixture – Ham – supplemented with 10% (v/v) heat-inactivated FBS, 
10 u/ml penicillin and 10 μg/ml streptomycin, in a humidified 5% CO2 atmosphere and at constant 
temperature (37 °C). Cells were co-transfected with EGFP and Kv1.3 plasmids (2 μg each), kindly 
provided by Prof. P. Fromherz (Max-Planck Institute for Biochemistry, Martinsried, Germany) 
[Kupper, 1998]. One to two days from transfection, fluorescent cells were pre-selected for 
electrophysiology (see below). Plasmids were amplified and purified from bacterial strains 
(HiSpeed Plasmid Maxi Kit, QIAGEN, Italy) and transfected with Lipofectamine™2000 one to two 
days after plating. If not otherwise indicated, reagents and culture media were purchased from Life 
Technologies (Italy).  
 
Electrophysiology with ELF-EMF exposure 
The electromagnetic field was generated by a 20 Hz sinusoidal current (provided by a function 
generator Agilent 33220A, Agilent Technologies Inc.) applied to a custom made solenoid, formed 
by an enamelled copper wire (0.45 mm wire diameter, 2000 turns/metre) wound on a plastic support 
(80 mm diameter, 10 layers of wires). The cell culture in the Petri dish was placed at the centre of 
the solenoid and exposed to a magnetic field orthogonal to the plane of adhesion (Figure 1). Two 
field intensities were employed as detailed in the Results section: ELF-EMF1 = 268 μT and ELF-
EMF2 = 902 μT (r.m.s. values measured with a Gauss meter Model 907, Magnetic Instrumentations 
Inc., Indianapolis, IN, USA).While for ELF-EMF1 the function generator was driving directly the 
solenoid, an amplifier was used to boost the signal to generate ELF-EMF2. The value of 20 Hz was 
chosen basing on previous observations [Medlam et al., 2008; Medlam, 2009; Cecchetto et al., 
2013; Cecchetto et al., 2014]. Experiments were performed at room temperature, with the 
extracellular recording solution (see below) monitored by a digital thermometer (GTH 1150, 
Greisinger). 
Kv1.3 potassium currents were recorded 24-48 h after transfection by patch-clamp in whole-cell 
voltage-clamp configuration. Recordings were performed before, during and after field exposure 
using an Axopatch 200B amplifier (Molecular Devices, USA) connected to the PC through a BNC-
2110 Shielded Connector Block (National Instruments Corp, Austin, TX, USA) along with a PCI-
6259 PCI Card (National Instruments Corp, Austin, TX, USA). WinWCP (Strathclyde 
Electrophysiology Software, University of Strathclyde, Glasgow, UK) was used for data acquisition 
and data analysis.  Raw traces were low-pass filtered at 3.3 kHz and sampled at 10 kHz. 
Micropipettes were pulled from borosilicate glass capillaries (GB150T-10, Science Products 
GmbH, Hofheim, Germany) using a P-97 Flaming/Brown Micropipette Puller (Sutter Instruments 
Corp., Novato, CA, USA). Extracellular and intracellular solutions contained, respectively (in mM): 
135.0 NaCl, 5.4 KCl, 1.0 MgCl2, 1.8 CaCl, 10.0 glucose, 5.0 HEPES (adjusted to pH 7.4 with 1N 
NaOH); 140.0 KCl, 2.0 MgCl2, 5.0 EGTA, 5.0 HEPES (adjusted to pH 7.3 with 1N KOH). The 
resistance of the micropipettes in extracellular solution, when filled with intracellular solution, 
ranged from 2 to 3 MΩ. Current transients due to capacitive (stray, pipette and membrane) 
components were cancelled through the amplifier compensation circuits, whereas leakage currents 
were subtracted using a P/4 protocol. The voltage clamp protocol consisted of a depolarizing test 
pulse of +100 mV amplitude from a –90 mV holding potential for 200 ms, thus obtaining, within 
the pulse duration, a full  Kv1.3  activation [Grissmer et al., 1994; Marom and Levitan, 1994]. 
Depolarizing pulses were applied, with a few exceptions as detailed in the text, at time intervals  > 
30 s to avoid cumulative inactivation of the channel [Cook and Fadool, 2002; Grissmer et al., 1994; 
Marom and Levitan, 1994]. The steady-state potassium conductance for activation, gK, was 
computed from potassium currents (see below) and estimating the potassium reversal potential from 
intra- and extracellular recording solutions using the Nernst equation. During exposure, a 20 Hz 
modulation artefact was seen in the electrophysiological trace (see Figure 2B, exposure trace). 
Thus, as the artefact was masking the peak potassium current, gK was estimated from the potassium 
current averaged across the last full sinusoidal period (50 ms duration) during the test pulse. 
Similarly, in the absence of the field, currents were averaged across the last 50 ms of the pulse. As 
such, the measures represented approximations to the Kv1.3 steady-state conductance after full 
channel activation while neglecting an error introduced by slow inactivation [Grissmer et al., 1994; 
Marom and Levitan, 1994]. Statistical analysis was performed using a GraphPad Prism (GraphPad 
Software Inc., Version 5.01) as detailed in the text. 
 
 RESULTS AND DISCUSSION 
The effect of ELF-EMF on Kv1.3 was investigated by exposing Kv1.3 expressing CHO-K1 cells to 
a field and monitoring changes of the steady-state potassium current by patch-clamp in whole-cell 
voltage-clamp configuration. Potassium currents were activated throughout the experiment by 
applying depolarizing test pulses of 200 ms duration to +10 mV and then computing the 
corresponding steady-state conductance, gK, as described in ‘Materials and Methods’. Pulses were 
repeated to record currents prior, during and after cell exposure to ELF-EMF, the field being 
applied one minute after entering the whole cell configuration, held for 3 min and then removed. 
Kv1.3 currents recorded from one representative cell exposed to the ELF-EMF2-type field are 
shown in Figure 2. Figure 2A shows one representative cell during the whole-cell patch-clamp 
procedure. In Figure 2B three superimposed Kv1.3 current traces recorded under exposure of ELF-
EMF2 are reported: the first one recorded 1 min before exposure (labelled as PRE), the second one 
recorded during exposure (i.e., at 3 min from the onset of field application, labelled as 
EXPOSURE) and the third one at 1 min after the end of exposure (labelled as POST). In those 
traces, an increase of the Kv1.3 steady-state potassium current can be appreciated during the 
exposure phase. The increase with respect to pre-exposure conditions was nearly 50 percent which 
can be recognized despite a 20 Hz sinusoidal modulation artefact obscuring the current trace. 
Interestingly, such enhancement of the Kv1.3 current lasted, in part, even beyond field application. 
This is exemplified in Figure 2B, as seen in the trace recorded 1 min after field removal  (the POST 
trace) where the current intensity is still about 10 percent higher than in the pre-exposure phase. 
We performed a statistical analysis of the effect of ELF-EMF on Kv1.3 focusing on the evolution of 
the potassium current response over time and on its dependency on the field intensity. Two cell 
populations were analysed: one exposed to the lower intensity field, ELF-EMF1, and one to ELF-
EMF2 (see Materials and Methods). Percentage conductance changes of the steady-state potassium 
conductance,  (%), are reported over time for four cells (two exposed to ELF-EMF1 and two to 
ELF-EMF2) in Figure 3A. Each point in the plots represent the value of  derived from one 
single depolarizing test pulse. Note that the time interval between subsequent pulses was chosen to 
be larger than 30 s in order to avoid cumulative inactivation of the channel [Cook and Fadool, 2002; 
Grissmer et al., 1994; Marom and Levitan, 1994] and consequent misjudgements on the effect of 
the field. Only in one case the inter-pulse interval was of 10 s, that is, at the transition from the end 
of exposure to the post-exposure period. In fact, an appreciable conductance drop is seen at this first 
post-exposure checkpoint in three out of four cells (namely cells 1, 3 and 4), which can likely be 
ascribed to cumulative inactivation. The plots demonstrate the large variability we encountered 
across cells both in terms of dynamics of the response and of its extent: cells 1 and 2, exposed to the 
low intensity field, show a gradual increase of  from the start of exposure, reaching a maximum 
at the end of field application (3 min from the application onset) and then smoothly decreasing 
across the following 3 min after field removal. Cells 3 and 4, instead, present an abrupt increase 
right after field application and then a progressive decrease which continues during the post 
exposure period. In terms of the effect’s extent,  varies between 30 to nearly 240 percent across 
the four cells. 
In spite of these representative examples, we observed a significant number of cells that did not 
clearly respond to the field, and this under both exposures. Thus, when considering averaged 
responses over the entire cell populations, only a slight tendency to  increase emerged (Figure 
3B).  Interestingly, however, the time course of  was differing between ELF-EMF1 and ELF-
EMF2 treated cells. In the first case, cells were responding with a slow  increase reaching a 
steady-state after about 1 min from the exposure onset; in the second case, the conductance 
increased suddenly upon field application. 
A clearer picture of the effect of ELF-EMF1 and ELF-EMF2 on Kv1.3 emerged from the analysis of 
the population distributions with respect to . In particular, we considered the distributions of 
, the maximum  observed irrespective of its time of occurrence within the exposure 
window, for three different cell populations (Figure 4): (i) one exposed to ELF-EMF1, (ii) one 
exposed to ELF-EMF2 and one not exposed to the field (control). The control, which was assumed 
having a normal distribution with respect to , was tested for normality and fitted with a 
Gaussian curve (least square fit, dark line in Figure 4). By comparing ELF-EMF1 and ELF-EMF2 
distributions with the normally distributed control, we evidenced how cell exposure resulted in a 
deformation of the distribution due to the higher number of cells showing a  increase under field 
exposure (Figure 4). The effect appeared to be more pronounced for ELF-EMF2 as compared to 
ELF-EMF1, with the fraction of cells falling beyond 3(standard deviation, SD) at the right side 
of the control curve accounting for a 26% and 37%, respectively. The distribution of  time 
occurrences observed in these outliers can be summarized as follows: 21% of cells for ELF-EMF1 
and 13% for ELF-EMF2 at 10 s from field application; 33% for ELF-EMF1 and 44% for ELF-EMF2 
at 1 min; 46% for ELF-EMF1 and 44% for ELF-EMF2 at 3 min. We also compared the medians of 
the distributions through a Wilcoxon Signed Rank Test (median equal to zero as null hypothesis) 
and found that, contrary to the control,  medians of ELF-EMF1-exposed and ELF-EMF2-exposed 
populations differed significantly from zero (p = 0.014 and p = 0.0001, respectively).  
Taken together these results provided a strong indication that ELF-EMF can enhance Kv1.3 
conductance. The effect, however, is distributed unevenly across cells, which led to asymmetry in 
the frequency distributions reported in Figure 4. Increasing field intensity further increases the 
number of responsive cells. It is noteworthy that the maximum Kv1.3 conductance enhancement 
was frequently found at least 1 min from the start of exposure and the effect was lasting beyond 
field removal. Although it is difficult to argue about molecular mechanisms on this basis, we may 
infer that the activation of intracellular signalling pathways of Kv1.3 modulation could be involved 
[Cook and Fadool, 2002; Fadool et al., 2000; Fadool and Levitan, 1998; Bowlby et al., 1997], thus 
delaying the onset of the response and justifying its persistence in the absence of the field. 
Whatever the mechanism is, our findings suggest that ELF-EMF may produce cellular effects 
through Kv1.3 modulation, particularly at the level of the immune and nervous systems. Starting 
from these observations, and before considering implications for therapy and prevention, additional 
studies will be required to elucidate mechanisms and assess whether the effect is found also in 
native Kv1.3-expressing cells.  
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Figure 1 Experimental setup for ELF-EMF exposure and simultaneous whole-cell patch-
clamp. A. Photograph showing the main components of the setup: the solenoid (S) formed by a 
copper wire wound on a plastic spool is visible at the foreground with the Petri dish (D) at the 
centre; a patch-clamp pipette (P) points to a cell beneath the microscope objective; the Ag/AgCl 
reference electrode (R) is immersed in the recording solution close to the border of the Petri dish. B: 
Sketch of the Petri dish and field direction (dashed lines). Blow up: CHO-K1 cells cultured at the 
bottom of the dish as observed by bright-field microscopy (Olympus BX51WI microscope, water 
immersion 10x objective, 0.30 N.A., 6.5 mm W. D., from Olympus Italia SRL, Milan, Italy). 
 
  
Figure 2 Effect of ELF-EMF on Kv1.3 potassium current. A. Bright-field micrograph of a 
Kv1.3 expressing CHO-K1 cell during an experiment of exposure to the ELF-EMF2 field. The cell 
was contacted by a patch-clamp pipette for recording potassium currents that are reported in B. B: 
Example of three whole-cell current traces recorded, respectively, at 1 min before exposure (PRE), 
under field exposure at 3 min from the start of field application (EXPOSURE) and 1 min after the 
field was removed (POST). A potassium current increase of about 50 percent can be clearly 
observed in the EXPOSURE trace, together with a 20 Hz AC modulation artefact. The increase 
persists till 1 min post-exposure, although to a reduced extent with respect to the exposure phase. 
Top-right: voltage-clamp protocol for Kv1.3 current activation. 
 Figure 3 Average response of Kv1.3 steady-state conductance to ELF-EMF1 and ELF-EMF2.  
A:  Response of representative cells (cells 1 and 2 exposed to ELF-EMF1, cells 3 and 4 exposed to 
ELF-EMF2) in terms of  percentage changes with respect to pre-exposure ( ). B: Average 
 across the population of cells exposed either to ELF-EMF1 (N = 92) or to ELF-EMF2 (N = 44). 
Data are plotted as mean ± SEM. Only slightly significant increases of conductance were observed 
in the two populations: at 1 and 3 min of exposure for ELF-EMF1 (p = 0.065 and p = 0.086, 
respectively) and at 10 s and 1 min for ELF-EMF2 (p = 0.067 and p = 0.074, respectively).  Note the 
different dynamics of the response to the field in the two cell populations with ELF-EMF1-exposed 
cells showing a gradual rise in conductance and then a plateau, and ELF-EMF2-exposed cells an 
abrupt conductance increase upon field application followed by a gradual decrease after 1 min of 
exposure. 
 
  
Figure 4. Distributions of maximum percentage gK changes. Frequency distributions of 
in control, ELF-EMF1-exposed and ELF-EMF2-exposed cell populations built with a fixed 
bin equal to 6% (Control: N = 16; ELF-EMF1: N = 92; ELF-EMF 2: N = 44. Total number of cells: 
N = 156). Raw control data were tested for normality using a D'Agostino & Pearson omnibus K2 
test (p = 0.89; null hypothesis: non-Gaussian distribution) and fitted with a Gaussian curve (least 
squares fit, R2=0.937). The same normality test performed on raw data from ELF-EMF1 and ELF-
EMF2 cell populations evidenced, in both cases, a significant deviation from normality (p < 0.0001 
for both). 
 
